Back

MerTK-dependent efferocytosis by monocytic-MDSCs mediates resolution of post-lung transplant injury

Leroy, V.; Manual Kollareth, D. J.; Tu, Z.; Valisno, J.; Woolet-Stockton, M. J.; Saha, B.; Emtiazjoo, A.; Rackauskas, M.; Moldawer, L.; Efron, P.; Cai, G.; Atkinson, C.; Upchurch, G. R.; Sharma, A. K.

2024-01-23 immunology
10.1101/2024.01.18.576261 bioRxiv
Show abstract

ABSTRACTO_ST_ABSRationaleC_ST_ABSPatients with end stage lung diseases require lung transplantation (LTx) that can be impeded by ischemia-reperfusion injury (IRI) leading to subsequent chronic lung allograft dysfunction (CLAD) and inadequate outcomes. ObjectivesWe examined the undefined role of MerTK (receptor Mer tyrosine kinase) on monocytic myeloid-derived suppressor cells (M-MDSCs) in efferocytosis (phagocytosis of apoptotic cells) to facilitate resolution of lung IRI. MethodsSingle-cell RNA sequencing of lung tissue and BAL from post-LTx patients was analyzed. Murine lung hilar ligation and allogeneic orthotopic LTx models of IRI were used with Balb/c (WT), cebpb-/- (MDSC-deficient), Mertk-/- or MerTK-CR (cleavage resistant) mice. Lung function, IRI (inflammatory cytokine and myeloperoxidase expression, immunohistology for neutrophil infiltration), and flow cytometry of lung tissue for efferocytosis of apoptotic neutrophils were assessed in mice. Measurements and Main ResultsA significant downregulation in MerTK-related efferocytosis genes in M-MDSC populations of CLAD patients compared to healthy subjects was observed. In the murine IRI model, significant increase in M-MDSCs, MerTK expression and efferocytosis was observed in WT mice during resolution phase that was absent in cebpb-/- Land Mertk-/- mice. Adoptive transfer of M-MDSCs in cebpb-/- mice significantly attenuated lung dysfunction, and inflammation leading to resolution of IRI. Additionally, in a preclinical murine orthotopic LTx model, increases in M-MDSCs were associated with resolution of lung IRI in the transplant recipients. In vitro studies demonstrated the ability of M-MDSCs to efferocytose apoptotic neutrophils in a MerTK-dependent manner. ConclusionsOur results suggest that MerTK-dependent efferocytosis by M-MDSCs can significantly contribute to the resolution of post-LTx IRI.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
The Journal of Heart and Lung Transplantation
10 papers in training set
Top 0.1%
10.2%
2
Frontiers in Immunology
586 papers in training set
Top 1.0%
6.9%
3
The Journal of Infectious Diseases
182 papers in training set
Top 0.6%
4.9%
4
European Respiratory Journal
54 papers in training set
Top 0.4%
4.0%
5
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.2%
4.0%
6
JCI Insight
241 papers in training set
Top 1%
3.9%
7
Immunology & Cell Biology
11 papers in training set
Top 0.1%
3.6%
8
Nature Communications
4913 papers in training set
Top 39%
3.6%
9
PLOS ONE
4510 papers in training set
Top 38%
3.6%
10
Journal of Clinical Investigation
164 papers in training set
Top 1.0%
3.6%
11
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.3%
2.5%
50% of probability mass above
12
American Journal of Transplantation
15 papers in training set
Top 0.1%
1.8%
13
Cytotherapy
14 papers in training set
Top 0.2%
1.5%
14
Cells
232 papers in training set
Top 3%
1.4%
15
Transplantation
13 papers in training set
Top 0.3%
1.4%
16
Scientific Reports
3102 papers in training set
Top 64%
1.4%
17
Stem Cell Reports
118 papers in training set
Top 0.6%
1.2%
18
Journal of Leukocyte Biology
40 papers in training set
Top 0.3%
1.2%
19
Biomedicines
66 papers in training set
Top 2%
1.2%
20
Thorax
32 papers in training set
Top 0.6%
1.1%
21
International Journal of Molecular Sciences
453 papers in training set
Top 12%
1.0%
22
iScience
1063 papers in training set
Top 24%
1.0%
23
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.0%
24
Immunology
29 papers in training set
Top 0.8%
0.9%
25
American Journal of Physiology-Lung Cellular and Molecular Physiology
39 papers in training set
Top 0.3%
0.9%
26
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 2%
0.9%
27
Clinical Immunology
21 papers in training set
Top 0.5%
0.9%
28
Nature Immunology
71 papers in training set
Top 2%
0.8%
29
Science Advances
1098 papers in training set
Top 27%
0.8%
30
eLife
5422 papers in training set
Top 57%
0.8%